| __timestamp | ACADIA Pharmaceuticals Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 56369000000 |
| Thursday, January 1, 2015 | 76369000 | 62786000000 |
| Friday, January 1, 2016 | 4406000 | 62427000000 |
| Sunday, January 1, 2017 | 13060000 | 62453000000 |
| Monday, January 1, 2018 | 18330000 | 65724000000 |
| Tuesday, January 1, 2019 | 19598000 | 70421000000 |
| Wednesday, January 1, 2020 | 20550000 | 80591000000 |
| Friday, January 1, 2021 | 19141000 | 86645000000 |
| Saturday, January 1, 2022 | 10166000 | 100551000000 |
| Sunday, January 1, 2023 | 45731000 | 42907000000 |
| Monday, January 1, 2024 | 115557000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical landscape, understanding cost structures is crucial. This analysis delves into the cost of revenue trends for Dr. Reddy's Laboratories Limited and ACADIA Pharmaceuticals Inc. from 2014 to 2023. Dr. Reddy's, a global player, consistently shows a robust cost of revenue, peaking at approximately $115.6 billion in 2024, reflecting its expansive operations. In contrast, ACADIA, a niche player, exhibits more volatility, with costs ranging from $4.4 million in 2016 to $76.4 million in 2015. Notably, 2023 saw a significant drop for Dr. Reddy's, while ACADIA's costs surged by over 350% from the previous year. These insights highlight the contrasting scales and strategies of these companies, offering a window into their operational efficiencies and market challenges. Missing data for 2024 suggests potential reporting delays or strategic shifts, warranting further investigation.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs ACADIA Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs ACADIA Pharmaceuticals Inc.
Analyzing Cost of Revenue: AstraZeneca PLC and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Viatris Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs HUTCHMED (China) Limited